Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome

Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome

(2012) Ai-Ching Boon et al.   FREE RADICAL BIOLOGY AND MEDICINE

Bilirubin and beyond: A review of lipid status in Gilbert’s syndrome and its relevance to cardiovascular disease protection

(2012) A.C. Bulmer et al.   PROGRESS IN LIPID RESEARCH

Serum Bilirubin Links UGT1A1*28 Polymorphism and Predicts Long-Term Cardiovascular Events and Mortality in Chronic Hemodialysis Patients

(2011) Y.-H. Chen et al.   Clinical Journal of the American Society of Nephrology

Serum amyloid A in atherosclerosis

(2011) Victoria L. King et al.   CURRENT OPINION IN LIPIDOLOGY

Serum Bilirubin and Risk of Respiratory Disease and Death

(2011) Laura J. Horsfall   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Relationship Between Bilirubin Concentration, Coronary Endothelial Function, and Inflammatory Stress in Overweight Patients

(2011) Satoshi Yoshino et al.   Journal of Atherosclerosis and Thrombosis

Clinical implications of discordance between low-density lipoprotein cholesterol and particle number

(2011) James D. Otvos et al.   Journal of Clinical Lipidology

Inverse Association Between Total Bilirubin and Metabolic Syndrome in Rural Korean Women

(2011) Kyung-Min Kwon et al.   JOURNAL OF WOMENS HEALTH

Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults

(2011) S.H. Choi et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Waist Circumference as Compared with Body-Mass Index in Predicting Mortality from Specific Causes

(2011) Michael F. Leitzmann et al.   PLoS One

Decreased small dense LDL levels in Gilbert's syndrome

(2010) Serkan Tapan et al.   CLINICAL BIOCHEMISTRY

Correlation between Bilirubin Glucuronidation and Estradiol-3-Gluronidation in the Presence of Model UDP-Glucuronosyltransferase 1A1 Substrates/Inhibitors

(2010) J. Zhou et al.   DRUG METABOLISM AND DISPOSITION

Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress

(2010) Lucie Muchova et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Bilirubin concentration and cardiovascular risk profile

(2010) Giuseppe Lippi et al.   LIVER INTERNATIONAL

Heme Oxygenase-1/Carbon Monoxide

(2009) Stefan W. Ryter et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial

(2009) Charlotte Andersson et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection

(2008) Andrew C. Bulmer et al.   ATHEROSCLEROSIS

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

(2008) I. Holme et al.   JOURNAL OF INTERNAL MEDICINE